PAPILLARY THYROID MICROCARCINOMA: CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT, AND CONTROVERSIAL ISSUES

The main practical conclusion drawn from the current literature is that papillary thyroid microcarcinoma (PTMC) should not be regarded as a single biological entity, but rather as a heterogeneous group of tumors with varying risks of progression. This concept provides a rationale for the coexistence of several management strategies, including active surveillance, lobectomy, and, in selected patients, thermal ablation, without establishing any one of these approaches as a universal standard for all patients. The most important feature of the current debate is that disagreements among experts now primarily concern the boundaries of applicability of different management strategies, rather than the fundamental legitimacy of active surveillance as a management approach. Therefore, the most evidence-based approach in clinical practice is not to select a single universally applicable method, but to follow a stepwise assessment: ultrasound based risk stratification → cytology → anatomical extent of disease → risk of progression → patient preferences → selection of appropriate treatment.